Cardiff Oncology Cash Conversion Cycle 2011-2026 | CRDF

Annual Cash Conversion Cycle Cardiff Oncology

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
294	284	396	617	435	-	-	-244	-111	-142	-489	-17.6 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
617	-17.6 K	-1.66 K

Quarterly Cash Conversion Cycle Cardiff Oncology

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
297	351	493	-	296	236	152	-	116	354	795	-	319	224	605	-	373	353	450	-	1.82 K	1.82 K	663	-	346	266	262	-	-2.1 K	126	328	38	182	-154	-59.5	135	-140	-163	-245	114	-390	-1 K	-407	92.4	90.4	93	55.8	153	165	147	94.8	94.3	72.7	370	357	-	164	113	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.82 K	-2.1 K	179

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Heron Therapeutics HRTX	751	$ 0.8	2.7 %	$ 133 M	USA
Amphastar Pharmaceuticals AMPH	205	$ 19.23	-1.38 %	$ 899 M	USA
Altimmune ALT	7.85 K	$ 3.44	2.99 %	$ 303 M	USA
Aytu BioScience AYTU	174	$ 2.63	0.77 %	$ 16.5 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Incyte Corporation INCY	-54.7	$ 90.45	-0.36 %	$ 17.7 B	USA
Inovio Pharmaceuticals INO	1.91 K	$ 1.61	1.9 %	$ 35.7 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Kamada Ltd. KMDA	163	$ 8.2	-0.61 %	$ 260 M	Israel
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Karyopharm Therapeutics KPTI	72.5	$ 6.66	-12.71 %	$ 812 K	USA
Keros Therapeutics KROS	4.72	$ 11.24	2.55 %	$ 418 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Longeveron LGVN	-212	$ 0.95	-2.71 %	$ 16.7 B	USA
Denali Therapeutics DNLI	1.89	$ 21.09	4.56 %	$ 3.47 B	USA
Arbutus Biopharma Corporation ABUS	31.5	$ 4.42	4.25 %	$ 734 M	Canada